These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 36844204)
1. Risk factors for persistent tomographic abnormalities at 6 months of follow-up in a cohort of hospitalized patients with moderate and severe COVID-19 living at high altitude. Rincon-Alvarez E; Gonzalez-Garcia M; Ali-Munive A; Casas A; Proaños NJ; Giraldo-Cadavid LF; Moreno A; Pérez C; Rubiano W; Cogollo M; Parada-Tovar P; Torres-Duque CA Front Med (Lausanne); 2023; 10():1110535. PubMed ID: 36844204 [TBL] [Abstract][Full Text] [Related]
2. Effect of Altitude on Respiratory Functional Status in COVID-19 Survivors: Results from a Latin American Cohort-FIRCOV. Gochicoa-Rangel L; Arce SC; Aguirre-Franco C; Madrid-Mejía W; Gutiérrez-Clavería M; Noriega-Aguirre L; Schonffeldt-Guerrero P; Acuña-Izcaray A; Cortés-Telles A; Martínez-Valdeavellano L; Hernández-Rocha FI; Ceballos-Zúñiga O; Del Rio Hidalgo R; Sánchez S; Meneses-Tamayo E; Chérrez-Ojeda I; High Alt Med Biol; 2023 Mar; 24(1):37-48. PubMed ID: 36757307 [TBL] [Abstract][Full Text] [Related]
3. Residual radiological opacities correlate with disease outcomes in ICU-treated COVID-19. Björnson M; Svensson AM; He C; Sköld M; Nyrén S; Nygren-Bonnier M; Bruchfeld J; Runold M; Jalde FC; Kistner A Front Med (Lausanne); 2024; 11():1263511. PubMed ID: 38633311 [TBL] [Abstract][Full Text] [Related]
4. Oximetry at admission as a predictor of tomographic and functional impairment after 3-6 months in hospitalized patients with COVID-19. Villar PME; Mendes PRA; Kiyota TA; Engleitner HA; Tamesawa CS; Morello MM; Basso NN; Arruda LF; Vian BS; Ratti LDSR; de Oliveira LB; Lima ALCB; Ceccato HD; Silva JF; Villalba WO; Conterno LO; Resende MR; Pereira MC J Int Med Res; 2023 Jun; 51(6):3000605231177187. PubMed ID: 37291854 [TBL] [Abstract][Full Text] [Related]
5. Performance capacity evaluated using the 6-minute walk test: 5-year results in patients with diffuse systemic sclerosis and initial interstitial lung disease. Rizzi M; Sarzi-Puttini P; Airoldi A; Antivalle M; Battellino M; Atzeni F Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S142-7. PubMed ID: 26339893 [TBL] [Abstract][Full Text] [Related]
6. Pulmonary Function and Radiologic Features in Survivors of Critical COVID-19: A 3-Month Prospective Cohort. González J; Benítez ID; Carmona P; Santisteve S; Monge A; Moncusí-Moix A; Gort-Paniello C; Pinilla L; Carratalá A; Zuil M; Ferrer R; Ceccato A; Fernández L; Motos A; Riera J; Menéndez R; Garcia-Gasulla D; Peñuelas O; Bermejo-Martin JF; Labarca G; Caballero J; Torres G; de Gonzalo-Calvo D; Torres A; Barbé F; Chest; 2021 Jul; 160(1):187-198. PubMed ID: 33676998 [TBL] [Abstract][Full Text] [Related]
8. Severe SARS-CoV-2 pneumonia: Clinical, functional and imaging outcomes at 4 months. Noel-Savina E; Viatgé T; Faviez G; Lepage B; Mhanna LT; Pontier S; Dupuis M; Collot S; Thomas P; Idoate Lacasia J; Crognier L; Bouharaoua S; Silva Sifontes S; Mazieres J; Prévot G; Didier A Respir Med Res; 2021 Nov; 80():100822. PubMed ID: 34242974 [TBL] [Abstract][Full Text] [Related]
9. The Assessment of Functional Status Among COVID-19 Patients at Three Months Using Pulmonary Function Tests. Asija M; Dahiya S; Parsad R; Fotedar S; Sharma R; Bhatthi V Cureus; 2024 May; 16(5):e61221. PubMed ID: 38939290 [TBL] [Abstract][Full Text] [Related]
10. Lung function six months after severe COVID-19: Does time, in fact, heal all wounds? Bretas DC; Leite AS; Mancuzo EV; Prata TA; Andrade BH; Oliveira JDGF; Batista AP; Machado-Coelho GLL; Augusto VM; Marinho CC Braz J Infect Dis; 2022; 26(3):102352. PubMed ID: 35500646 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of long-term sequelae by cardiopulmonary exercise testing 12 months after hospitalization for severe COVID-19. Noureddine S; Roux-Claudé P; Laurent L; Ritter O; Dolla P; Karaer S; Claudé F; Eberst G; Westeel V; Barnig C BMC Pulm Med; 2023 Jan; 23(1):13. PubMed ID: 36635717 [TBL] [Abstract][Full Text] [Related]
12. Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19. ; Morin L; Savale L; Pham T; Colle R; Figueiredo S; Harrois A; Gasnier M; Lecoq AL; Meyrignac O; Noel N; Baudry E; Bellin MF; Beurnier A; Choucha W; Corruble E; Dortet L; Hardy-Leger I; Radiguer F; Sportouch S; Verny C; Wyplosz B; Zaidan M; Becquemont L; Montani D; Monnet X JAMA; 2021 Apr; 325(15):1525-1534. PubMed ID: 33729425 [TBL] [Abstract][Full Text] [Related]
13. Respiratory function and CT abnormalities among survivors of COVID-19 pneumonia: a nationwide follow-up study. Axelsson GT; Halldorsson AB; Jonsson HM; Eythorsson E; Sigurdardottir SE; Hardardottir H; Gudmundsson G; Hansdottir S BMJ Open Respir Res; 2022 Oct; 9(1):. PubMed ID: 36216402 [TBL] [Abstract][Full Text] [Related]
14. Follow-Up Analysis of Pulmonary Function, Exercise Capacity, Radiological Changes, and Quality of Life Two Months after Recovery from SARS-CoV-2 Pneumonia. Strumiliene E; Zeleckiene I; Bliudzius R; Samuilis A; Zvirblis T; Zablockiene B; Strumila A; Gruslys V; Malinauskiene L; Kasiulevicius V; Jancoriene L Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34204878 [No Abstract] [Full Text] [Related]
15. Association of abnormal pulmonary vasculature on CT scan for COVID-19 infection with decreased diffusion capacity in follow up: A retrospective cohort study. Salerno D; Oriaku I; Darnell M; Lanclus M; De Backer J; Lavon B; Gupta R; Jaffe F; Vega Sanchez ME; Kim V; PLoS One; 2021; 16(10):e0257892. PubMed ID: 34653196 [TBL] [Abstract][Full Text] [Related]
16. Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge. Sibila O; Perea L; Albacar N; Moisés J; Cruz T; Mendoza N; Solarat B; Lledó G; Espinosa G; Barberà JA; Badia JR; Agustí A; Sellarés J; Faner R Respir Res; 2022 Feb; 23(1):37. PubMed ID: 35189887 [TBL] [Abstract][Full Text] [Related]
17. Health-Related Quality of Life Improves in Parallel with FEV1 and 6-Minute Walking Distance Test at Between 3 and 12 Months in Critical COVID-19 Survivors. André S; Bruyneel AV; Chirumberro A; Roman A; Claus M; Alard S; De Vos N; Bruyneel M Am J Med Open; 2023 Dec; 10():100055. PubMed ID: 39035247 [TBL] [Abstract][Full Text] [Related]
18. Long-Term Characteristics of Severe COVID-19: Respiratory Function, Functional Capacity, and Quality of Life. Sirayder U; Inal-Ince D; Kepenek-Varol B; Acik C Int J Environ Res Public Health; 2022 May; 19(10):. PubMed ID: 35627841 [TBL] [Abstract][Full Text] [Related]
19. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Wu X; Liu X; Zhou Y; Yu H; Li R; Zhan Q; Ni F; Fang S; Lu Y; Ding X; Liu H; Ewing RM; Jones MG; Hu Y; Nie H; Wang Y Lancet Respir Med; 2021 Jul; 9(7):747-754. PubMed ID: 33964245 [TBL] [Abstract][Full Text] [Related]